MICs of isoniazid, rifampin may predict tuberculosis relapse

August 30, 2018

(HealthDay)—In pretreatment isolates of Mycobacterium tuberculosis, higher minimum inhibitory concentrations (MICs) of isoniazid and rifampin below the standard resistance breakpoint are associated with increased risk of relapse, according to a study published in the Aug. 30 issue of the New England Journal of Medicine.

Roberto Colangeli, Ph.D., from the Rutgers-New Jersey Medical School in Newark, and colleagues analyzed pretreatment isolates of M. tuberculosis from patients who subsequently had a relapse or were cured to determine the MIC values of isoniazid and rifampin that were below the standard resistance breakpoint. This analysis was combined with clinical, radiologic, and laboratory data to generate predictive relapse models, which were then validated.

The researchers found that the mean MIC of isoniazid below the breakpoint was 0.0334 ± 0.0085 µg/mL and 0.0286 ± 0.0092 µg/mL in the relapse and cure groups, respectively. This represented a 1.17-fold higher value in the relapse group. For rifampin, the corresponding MIC values were 0.0695 ± 0.0276 µg/mL and 0.0453 ± 0.0223 µg/mL, representing a 1.53-fold higher value in the relapse group. In a multivariable analysis, higher MIC values remained associated with relapse. The area under the curve was 0.779 in an of receiver-operating-characteristic curves of relapse based on these MIC values.

"Higher pretreatment MIC values for either isoniazid or were associated with an increased risk of relapse, even after accounting for other potential risk factors for ," write the authors of an accompanying editorial.

Explore further: Relapse risk up with low vitamin D levels in ulcerative colitis

More information: Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Related Stories

Relapse risk up with low vitamin D levels in ulcerative colitis

February 1, 2017
(HealthDay)—For patients with ulcerative colitis (UC), serum vitamin D levels ≤35 ng/mL are associated with increased risk of clinical relapse, according to a study published in the February issue of Clinical Gastroenterology ...

Higher doses of rifampin appear more effective in fighting tuberculosis without increasing risk of adverse events

June 29, 2018
Higher daily doses of rifampin, a cornerstone of tuberculosis treatment, killed more TB bacteria in sputum cultures, and the higher doses did so without increasing the adverse effects of treatment, according to a randomized ...

Molecular minimal disease in remission predicts AML relapse

March 29, 2018
(HealthDay)—The detection of molecular minimal residual disease is associated with increased relapse rates in acute myeloid leukemia (AML), according to a study published in the March 29 issue of the New England Journal ...

Dose-dependent link between cannabis use, psychosis relapse

September 29, 2016
(HealthDay)—Cannabis use may raise the risk of psychosis relapse, according to a study published online Sept. 28 in JAMA Psychiatry.

Relapse in major depression linked to brain cortical changes

March 30, 2018
(HealthDay)—For patients with major depressive disorder (MDD), relapse is associated with brain cortical changes over two years, according to a study published online March 28 in JAMA Psychiatry.

ICAAC: Moxifloxacin regimens are not noninferior for TB

September 8, 2014
(HealthDay)—For patients with uncomplicated, smear-positive pulmonary tuberculosis, moxifloxacin-containing regimens over four months are not noninferior to a control regimen, according to a study published online Sept. ...

Recommended for you

A versatile vaccine that can protect mice from emerging tick-borne viruses

December 18, 2018
A group of researchers led by Michael Diamond of Washington University School of Medicine in St. Louis have developed a vaccine that is effective in mice against Powassan virus, an emerging tick-borne virus that can cause ...

How cholera bacteria make people so sick

December 18, 2018
The enormous adaptability of the cholera bacterium explains why it is able to claim so many victims. Professor Ariane Briegel from the Leiden Institute of Biology has now discovered that this adaptability is due to rapid ...

Green leafy vegetables may prevent liver steatosis

December 17, 2018
A larger portion of green leafy vegetables in the diet may reduce the risk of developing liver steatosis, or fatty liver. In a study published in PNAS researchers from Karolinska Institutet in Sweden show how a larger intake ...

Discovery of novel mechanisms that cause migraines

December 17, 2018
Researchers at CNRS, Université Côte d'Azur and Inserm have demonstrated a new mechanism related to the onset of migraine. They found how a mutation that causes dysfunction in a protein which inhibits neuronal electrical ...

RNA processing and antiviral immunity

December 14, 2018
The RIG-I like receptors (RLRs) are intracellular enzyme sentries that detect viral infection and initiate a first line of antiviral defense. The cellular molecules that activate RLRs in vivo are not clear.

Faster test for Ebola shows promising results in field trials

December 13, 2018
A team of researchers with members from the U.S., Senegal and Guinea, in cooperation with Becton, Dickinson and Company (BD), has developed a faster test for the Ebola virus than those currently in use. In their paper published ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.